Kisqali 600 MG daily dose UU 63S
Ended Awarded Last action
- Contract number
- SPE2DR26F9GG4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $40,888
Award facts
- Contract value 100% obligated
- $40,887.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $40,887.60 to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Kisqali 600 mg daily dose medication in quantities of 63 units. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 9, 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The parent IDC enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen Drug Corp's demonstrated capability to meet federal procurement requirements through competitive awards, combined with its extensive portfolio of medical product deliveries across multiple therapeutic domains, positions it as a significant vendor within the DLA's pharmaceutical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26F9GG4?
SPE2DR26F9GG4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26F9GG4 worth?
The government has obligated $40,888 on SPE2DR26F9GG4.
Is contract SPE2DR26F9GG4 an order under another contract?
Yes. SPE2DR26F9GG4 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9GG4 competed?
The extent of competition for SPE2DR26F9GG4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award